Molecular alterations of PI3K/Akt/mTOR pathway: A therapeutic target in endometrial cancer

Athanasia Pavlidou, Nikos F. Vlahos

    Research output: Contribution to journalArticle

    Abstract

    It is well established that the PI3K/Akt/mTOR pathway plays a central role in cell growth and proliferation. It has also been suggested that its deregulation is associated with cancer. Genetic alterations, involving components of this pathway, are often encountered in endometrial cancers. Understanding and identifying the rate-limiting steps of this pathway would be crucial for the development of novel therapies against endometrial cancer. This paper reviews alterations in the PI3K/Akt pathway, which could possibly contribute to the development of endometrial cancer. In addition, potential therapeutic targets of this pathway with emphasis on the mTOR inhibitors are also presented.

    Original languageEnglish (US)
    Article number709736
    JournalScientific World Journal
    Volume2014
    DOIs
    StatePublished - 2014

    Fingerprint

    Endometrial Neoplasms
    Phosphatidylinositol 3-Kinases
    cancer
    Deregulation
    Cell proliferation
    Cell growth
    deregulation
    Therapeutics
    Cell Proliferation
    inhibitor
    Growth
    Neoplasms

    ASJC Scopus subject areas

    • Biochemistry, Genetics and Molecular Biology(all)
    • Environmental Science(all)
    • Medicine(all)

    Cite this

    Molecular alterations of PI3K/Akt/mTOR pathway : A therapeutic target in endometrial cancer. / Pavlidou, Athanasia; Vlahos, Nikos F.

    In: Scientific World Journal, Vol. 2014, 709736, 2014.

    Research output: Contribution to journalArticle

    @article{9eb11a51e17e421996c17b9aaee9737a,
    title = "Molecular alterations of PI3K/Akt/mTOR pathway: A therapeutic target in endometrial cancer",
    abstract = "It is well established that the PI3K/Akt/mTOR pathway plays a central role in cell growth and proliferation. It has also been suggested that its deregulation is associated with cancer. Genetic alterations, involving components of this pathway, are often encountered in endometrial cancers. Understanding and identifying the rate-limiting steps of this pathway would be crucial for the development of novel therapies against endometrial cancer. This paper reviews alterations in the PI3K/Akt pathway, which could possibly contribute to the development of endometrial cancer. In addition, potential therapeutic targets of this pathway with emphasis on the mTOR inhibitors are also presented.",
    author = "Athanasia Pavlidou and Vlahos, {Nikos F.}",
    year = "2014",
    doi = "10.1155/2014/709736",
    language = "English (US)",
    volume = "2014",
    journal = "The Scientific World Journal",
    issn = "2356-6140",
    publisher = "Hindawi Publishing Corporation",

    }

    TY - JOUR

    T1 - Molecular alterations of PI3K/Akt/mTOR pathway

    T2 - A therapeutic target in endometrial cancer

    AU - Pavlidou, Athanasia

    AU - Vlahos, Nikos F.

    PY - 2014

    Y1 - 2014

    N2 - It is well established that the PI3K/Akt/mTOR pathway plays a central role in cell growth and proliferation. It has also been suggested that its deregulation is associated with cancer. Genetic alterations, involving components of this pathway, are often encountered in endometrial cancers. Understanding and identifying the rate-limiting steps of this pathway would be crucial for the development of novel therapies against endometrial cancer. This paper reviews alterations in the PI3K/Akt pathway, which could possibly contribute to the development of endometrial cancer. In addition, potential therapeutic targets of this pathway with emphasis on the mTOR inhibitors are also presented.

    AB - It is well established that the PI3K/Akt/mTOR pathway plays a central role in cell growth and proliferation. It has also been suggested that its deregulation is associated with cancer. Genetic alterations, involving components of this pathway, are often encountered in endometrial cancers. Understanding and identifying the rate-limiting steps of this pathway would be crucial for the development of novel therapies against endometrial cancer. This paper reviews alterations in the PI3K/Akt pathway, which could possibly contribute to the development of endometrial cancer. In addition, potential therapeutic targets of this pathway with emphasis on the mTOR inhibitors are also presented.

    UR - http://www.scopus.com/inward/record.url?scp=84893821223&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=84893821223&partnerID=8YFLogxK

    U2 - 10.1155/2014/709736

    DO - 10.1155/2014/709736

    M3 - Article

    C2 - 24526917

    AN - SCOPUS:84893821223

    VL - 2014

    JO - The Scientific World Journal

    JF - The Scientific World Journal

    SN - 2356-6140

    M1 - 709736

    ER -